Boehringer Ingelheim, Evotec and BioMérieux Launch Aurobac, a joint venture to fight Antimicrobial Resistance – News & Updates
Evotec Celebrates Opening Of US Headquarters Facility Expansion In Princeton New Jersey
EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST QUARTER 2022 ON 11 MAY 2022
Evotec SE General Corporate Statement By Foreign Issuer (Form6) (0001654954-23-003689) - Evotec (OTC:EVOTF) - Benzinga
Mubadala Investment Company and Novo Holdings A/S Invest € 250 M in Evotec Se | Mubadala
EVOTEC : EVT Stock Price | DE0005664809 | MarketScreener
Aktien – DE0005664809 – Evotec SE Inhaber-Aktien o.N. – Quotrix
EVOTEC SE : EVT Stock Price | DE0005664809 | MarketScreener
Evotec Aktie | Chart | WKN 566480, ISIN DE0005664809 | aktiencheck.de
EVT 17.57 EUR - TeleTrader.com
Evotec (EVT) • Aktie • 566480 / DE0005664809
EVOTEC SE : Kurs Aktie Börse | 566480 | DE0005664809 | MarketScreener
EVOTEC AG (DE0005664809) Assembleia Geral de Acionistas O emitente em referência anunciou a realização de uma assembleia de a
Evotec announces agreement with Janssen to develop immune-based therapies
Evotec Aktie
EVOTEC SE: storico delle operazioni in Borsa EVOTEC SE | EVT | DE0005664809 | MarketScreener
CEBINA announces the launch of Danube Labs, a partnership with Evotec to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions
TecDAX | Evotec Aktie: EU will. Investition von 150 Mio EUR für zweite biopharmazeutische Produktionsanlage - hohe Förderung. Hohe Nachfrage. Sofort Gewinnbringer.
